Le marché mondial de l'oxygénation par membrane extracorporelle était évalué à 546,73 millions de dollars américains en 2021 et devrait atteindre 677,64 millions de dollars américains d'ici 2028. Le marché devrait croître à un TCAC de 3,1 % entre 2022 et 2028.
L'oxygénation extracorporelle par membrane (oxygénation extracorporelle par membrane) est un traitement utilisé pour la circulation sanguine à travers un poumon artificiel. Le système aide à fournir une voie de contournement cur-poumon à l'extérieur du corps. Cela fournit également un soutien aux patients qui ont besoin d'une greffe de poumon. La croissance du marché de l'oxygénation par membrane extracorporelle est attribuée à la prévalence croissante des maladies cardiovasculaires et des insuffisances respiratoires et l'adoption croissante de l'oxygénation par membrane extracorporelle dans les procédures de transplantation pulmonaire. Cependant, les complications associées à l'oxygénation par membrane extracorporelle entravent la croissance du marché.
Perspectives stratégiques
Régions lucratives sur le marché de l'oxygénation extracorporelle des membranes
Informations sur le marché
L'adoption croissante de l'oxygénation par membrane extracorporelle dans les procédures de transplantation pulmonaire stimule la croissance du marché de l'oxygénation par membrane extracorporelle
La transplantation pulmonaire est une option de traitement vitale pour les patients souffrant de maladies pulmonaires en phase terminale, telles que comme BPCO, Fibrose pulmonaire idiopathique (FPI) ), et la mucoviscidose, pour améliorer la qualité de vie. L'oxygénation par membrane extracorporelle est un outil polyvalent utilisé dans toutes les phases de transplantation pulmonaire, telles que les périodes préopératoire, peropératoire et postopératoire. Il agit comme un pont pour le patient subissant une transplantation pulmonaire. Par conséquent, l'adoption de l'oxygénation par membrane extracorporelle pendant la transplantation pulmonaire se développe rapidement pour gérer les patients atteints d'une maladie pulmonaire potentiellement mortelle. Selon le Registre scientifique des receveurs de greffes (SRTR), environ 4 600 greffes de poumons sont réalisées dans le monde chaque année, dont 55 % en Amérique du Nord. Selon la même source, environ 2 759 patients ont subi une transplantation pulmonaire et environ 3 243 patients ont été ajoutés à la liste d'attente pour une transplantation pulmonaire aux États-Unis. Le dysfonctionnement primaire du greffon (DPI) est la principale cause de décès après une greffe pulmonaire. Ainsi, l'oxygénation par membrane extracorporelle est utilisée avant-dernière dans le traitement du DPI post-transplantation pulmonaire. Selon la National Library Medicine (NLM), en 2022, l'incidence globale du DPI est de 30 %, dans laquelle les facteurs de risque comprennent l'ischémie pulmonaire préopératoire du donneur, l'acquisition d'organes, les techniques de conservation et l'implantation et la reperfusion peropératoires d'organes. Ainsi, la demande d'équipements d'oxygénation par membrane extracorporelle augmente pour traiter les patients souffrant de DPI.
Insights basés sur les modalités
Le marché mondial de l'oxygénation par membrane extracorporelle, basé sur la modalité, est segmenté en oxygénation par membrane extracorporelle veino-artérielle, oxygénation par membrane extracorporelle veino-veineuse et oxygénation par membrane extracorporelle artério-veineuse. Le segment de l'oxygénation par membrane extracorporelle veino-artérielle détenait la plus grande part du marché en 2021. De plus, le même segment devrait enregistrer un TCAC le plus élevé de 3,8 % sur le marché au cours de la période de prévision. L'oxygénation par membrane extracorporelle veino-artérielle (VA) soutient le cur et les poumons du patient en poussant le sang dans le circuit sans traverser le cur du patient. Ce type d'oxygénation par membrane extracorporelle extrait le sang d'une grosse veine et le ramène dans une grosse artère, permettant au sang riche en oxygène de circuler dans le corps même si le cur est trop faible pour pomper. L'oxygénation par membrane extracorporelle veino-artérielle (oxygénation par membrane extracorporelle VA) a été largement appliquée au cours de la dernière décennie. C'est une option thérapeutique efficace et précieuse dans les chocs cardiogéniques réfractaires d'étiologies diverses. Il a montré des résultats prometteurs dans le cadre spécifique de l'arrêt cardiaque à l'hôpital, et les taux de survie avec de bons résultats neurologiques sont rapportés entre 20 % et 40 %.
Marché de l'oxygénation extracorporelle de la membrane, par modalité - 2021 et 2028< /h3>
Insights basés sur le groupe d'âge
En fonction du groupe d'âge, le marché mondial de l'oxygénation par membrane extracorporelle est segmenté en adultes, pédiatrie et nouveau-nés. Le segment des adultes détenait la plus grande part du marché en 2021 et devrait enregistrer un TCAC de 3,7 % au cours de la période 2022-2028. L'oxygénation par membrane extracorporelle aide les patients adultes souffrant d'insuffisance cardiaque ou respiratoire. De plus, les récentes avancées technologiques dans les circuits d'oxygénation à membrane extracorporelle ont entraîné une réduction du taux de problèmes techniques et de complications.
Oxygénation extracorporelle des membranes - Segmentation du marché
Le marché de l'oxygénation par membrane extracorporelle est segmenté en fonction de la modalité, de l'application, du groupe d'âge et de la géographie. En fonction de la modalité, le marché est segmenté en oxygénation par membrane extracorporelle veino-artérielle, oxygénation par membrane extracorporelle veino-veineuse , oxygénation artério-veineuse de la membrane extracorporelle. Basé sur l'application, le marché de l'oxygénation par membrane extracorporelle est divisé en respiratoire et en cardiologie. En termes d'utilisateur final, le marché de l'oxygénation par membrane extracorporelle est segmenté en adultes, pédiatrie et nouveau-nés. Par géographie, le marché de l'oxygénation par membrane extracorporelle est segmenté en Amérique du Nord (États-Unis, Canada et Mexique), en Europe (Royaume-Uni, Allemagne, France, Italie, Espagne et reste de l'Europe), en Asie-Pacifique (Chine, Japon, Inde, Australie, Corée du Sud et Reste de l'Asie-Pacifique), le Moyen-Orient & Afrique (Émirats arabes unis, Arabie saoudite, Afrique et reste du Moyen-Orient et Afrique) et Afrique du Sud et amp; Amérique centrale (Brésil, Argentine et reste de l'Amérique du Sud et centrale).
Les lancements et les approbations de produits sont des stratégies couramment adoptées par les entreprises pour étendre leur empreinte mondiale et leurs portefeuilles de produits afin de dominer la part de marché de l'oxygénation par membrane extracorporelle. De plus, les acteurs du marché misent sur la stratégie de partenariat pour élargir leur clientèle, ce qui leur permet de maintenir leur marque à travers le monde. Le marché devrait prospérer dans les années à venir grâce au développement de nouveaux produits innovants par les acteurs du marché.
Profils d'entreprise
- Groupe Terumo
- Medtronic Plc
- MicroPort Scientific Corporation
- LivaNova Plc
- Nipro Medical Corporation
- Eurosets SRL
- Getinge AB
- Braile Biomedica
- Fresenius Medical Care AG & Co KGaA
- ABIOMED Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global extracorporeal membrane oxygenation market based on modality is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. In 2021, the venoarterial extracorporeal membrane oxygenation segment accounted for the highest share, moreover the same segment is expected to grow faster at a CAGR of 3.8% in the forecast period.
The extracorporeal membrane oxygenation market majorly consists of the players such as Terumo Group, Medtronic Plc. MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and ABIOMED Inc.
The complications associated with extracorporeal membrane oxygenation is expected to restrict the market growth during the forecast period
Factors such as the rising prevalence of cardiovascular diseases and respiratory failures and further growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures.
Extracorporeal membrane oxygenation (ECMO) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream. The system enables to provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The main purpose of extracorporeal membrane oxygenation is to provide oxygen to the body to heal or rest.
The global extracorporeal membrane oxygenation market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 3.9% during the forecast period.
The List of Companies - Extracorporeal Membrane Oxygenation Market
- Terumo Group
- Medtronic Plc
- MicroPort Scientific Corporation
- LivaNova Plc
- Nipro Medical Corporation
- Eurosets S.R.L.
- Getinge AB
- Braile Biomedica
- Fresenius Medical Care AG & Co KGaA
- ABIOMED Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Nov 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Nov 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Nov 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)